IDiyas

For the Inventor, By the Inventor

South San Francisco, CA, United States of America

Alx Oncology Inc.


USPTO Granted Patents = 13



Trademarks = 1

Forward Citations = 46

Loading Chart...
Loading Chart...

12 inventors (with patents filed for the assignee):

goldMedal Hong Wan (12 out of 12 patents)

silverMedal Jaume Pons (11 out of 54 patents)

bronzeMedal Tracy Chia-Chien Kuo (10 out of 20 patents)

4.  Bang Janet Sim (10 out of 12 patents)

5.  Steven Elliot Kauder (7 out of 9 patents)

6.  William Don Harriman (3 out of 29 patents)

7.  Shelley Izquierdo (3 out of 4 patents)

8.  Sophia Randolph (3 out of 3 patents)

9.  Laura Deming (2 out of 2 patents)

10.  Corey Goodman (2 out of 2 patents)

11.  Jaume Pons (2 out of 4 patents)

12.  Marija Vrljic (1 out of 6 patents)


13 patents:

1. 12404340 - Antibodies against signal-regulatory protein alpha and methods of use (2025-09-02),
2. 12343377 - Combination therapies comprising a hypomethylation agent for treating cancer (2025-07-01),
3. 12098214 - Combination therapies for treating cancer (2024-09-24),
4. 11939393 - Antibodies against signal-regulatory protein alpha and methods of use (2024-03-26),
5. 11939385 - Activatable antibodies and methods of use thereof (2024-03-26),
6. 11639376 - Constructs having a SIRP-α domain or variant thereof (2023-05-02),
7. 11613564 - Methods of treating cancer (2023-03-28),
8. 11401338 - Antibodies against signal-regulatory protein alpha and methods of use (2022-08-02),
9. 11292850 - Antibodies against signal-regulatory protein α and methods of use (2022-04-05),
10. 11242404 - Antibodies against signal-regulatory protein alpha and methods of use (2022-02-08),
11. 11208459 - Constructs having a SIRP-alpha domain or variant thereof (2021-12-28),
12. 10696730 - Constructs having a SIRP-alpha domain or variant thereof (2020-06-30),
13. 10259859 - Constructs having a SIRP-α domain or variant thereof (2019-04-16),
Alx Oncology is a clinical-stage immuno-oncology company dedicated to developing therapies that target the CD47 checkpoint pathway to treat a broad range of solid and hematologic cancers. The company's lead product candidate, ALX148, is currently being evaluated in multiple clinical trials for various indications, including advanced solid tumors and hematologic malignancies.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

...
13 Patents

#80 in South San Francisco, CA

#5,472 in California

#23,099 in US

#43,615 in the World

...
South San Francisco, CA, United States of America

Alx Oncology Inc.

Forward Citations = 46

12 inventors:

goldMedal Hong Wan (12 out of 12 patents)

silverMedal Jaume Pons (11 out of 54 patents)

bronzeMedal Tracy Chia-Chien Kuo (10 out of 20 patents)

4.  Bang Janet Sim (10 out of 12 patents)

5.  Steven Elliot Kauder (7 out of 9 patents)

Please report any incorrect information to support@idiyas.com
Loading…